FOR AUTHORS
Submissions
Submission Preparation Checklist
All submissions must meet the following requirements.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the Editor.
- The text adheres to the stylistic and bibliographic requirements outlined in the Guidelines for Authors.
- The submission file is acceptable both in Microsoft Word (or RTF) and PDF format.
- Prepare your manuscript for the single-blind peer review. The text is typewritten, double-spaced throughout; pages are in A4 format and numbered, lines should be left numbered in continuum (10-digit numeric system); the text uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures and tables are placed at the end, rather than within the text. Figures should report legends below each figure.
- Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
- Authorship and Contributorship: All persons designated as authors should qualify for authorship according to the ICMJE criteria. Changes in Authorship: If authors request removal or addition of an author after manuscript submission or during the peer-review process, the journal editors should receive a letter clearly explaining the reason for the change. Please note that if your manuscript is accepted you will not be able to make any changes to the authors, or order of authors.
- Authors should suggest potential reviewers (name, affiliation and e-mail) for their manuscript and/or opposite reviewers. They must be indicated in the field "Comments for the Editor".
Original Research Articles
These articles should be 3,000-3,500 words long (main text). A structured (Background, Methods, Results, Conclusions) abstract up to 350 words long is required. The reference list should be selective, usually containing no more than about 35 selected references. Articles should be liberally illustrated with figures and diagrams (color encouraged). Although no strict upper limit of figures and tables is allowed, usually, up to 8 individual figures and tables can be included. Reports of clinical trials should adhere to the tenets of the CONSORT statement. A flow chart describing patients' progress through the trial must be provided. Reports of observational studies should adhere to the tenets of the STROBE statement. Reports of animal studies should adhere to the tenets of the ARRIVE statement.
Note that the main text of Original Articles is usually divided into the following sections and section order: Introduction, Results, Discussion, Conclusions, Materials and Methods, and References, Legends and Figures.
Review Articles
Review articles should be up to 5,000 words long (main text). Longer articles may be acceptable in special cases but should be discussed with the Editor(s) before submission. An abstract of up to 350 words in length is required. The reference list should be selective, containing about 100 selected references. Articles should be liberally illustrated with figures and diagrams (colour encouraged). There is no strict upper limit of figures and tables allowed.
A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines). Confinia Cephalalgica allows two different types of reviews: narrative review or systemic review, the latter of which must follow the PRISMA Reporting Guidelines, and in the case of meta-analysis, the MOOSE Guidelines.
Brief communications
Brief reports are short articles that deal with: (1) re-analyse part of an article that has previously been published; (2) present findings, or discuss issues of particular interest to the community, but are not suitable as a standard research article; (3) case report or small case series. These articles should be in principle around up to 2,000 words in length (main text). A structured abstract (Background, Case Presentation, Discussion, and Conclusions) up to 200 words in length is required. The reference list should be selective, containing no more than 20 selected references. Up to 3 figures and 2 table can be included. Case reports should adhere to the tenets of the CARE statement. Reports of observational studies should adhere to the tenets of the STROBE statement. Reports of animal studies should adhere to the tenets of the ARRIVE statement.
(3) Case reports generally fall into one of the following categories: Unreported or unusual side effects or adverse interactions involving medications; Unexpected or unusual presentations of a disease; New associations or variations in disease processes; Presentations, diagnoses and/or management of new and emerging diseases; An unexpected association between diseases or symptoms; An unexpected event in the course of observing or treating a patient; Findings that shed new light on the possible pathogenesis of a disease or an adverse effect.
Authors should seek written and signed consent to publish the information from the patients or their guardians prior to submission. The submitted manuscript must include a statement to this effect in the 'Consent' section, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images". The editorial office may request copies of the informed consent documentation upon submission of the manuscript.
Letters to the Editor
A Letter to the editor should be an article that raises issues of general interest to the broad readership of Confinia Cephalalgica. In case of re-analysis of a previously published article or brief research findings, please use “Brief communications” instead. Letters to the editor may be edited for clarity or length and may be subject to peer review at the editor’s discretion. These papers should be up to 1,000 words in length, and no abstract is needed. The reference list should be selective, containing no more than 10 selected references.
Editorials
They are short, invited opinion pieces that discuss an issue of immediate importance to the research community. Editorials should have fewer than 1,000 words total, no abstract, a minimal number of references up to 10, and up to 1 figure or table.
Pros and Cons
Pros and Cons are usually invited by the Editor: However, unsolicited proposals may be considered. Pros and Cons should be composed of two articles, each sustaining opposing or different views. Each article should be up to 2,500 words, tables (up to 3), figures (up to 3) and references (up to 50).
Copyright Notice
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Privacy Statement
Privacy & Data Protection
This journal is published and managed by PAGEPress® srl (Pavia, Italy, VAT IT02125780185), which acts as the data controller for all personal data processed through this platform, in compliance with Regulation (EU) 2016/679 (GDPR).
Personal data collected through the editorial system (names, email addresses, affiliations, manuscript data, review records) is processed exclusively for the management of the peer review and publication workflow. We do not sell or share your data with third parties for marketing purposes.
For full details on data categories, legal bases, retention periods, your rights under GDPR, and how to exercise them, please read our complete Privacy Policy. Contact: office@pagepress.org.